EPR Properties vs Tempus AI — how do they compare? EPR Properties trades at $54.41 (market cap $4.17B), while Tempus AI trades at $69.59 (market cap $12.58B). The key difference: Tempus AI is far larger — about 3× EPR Properties's market cap, and EPR Properties pays a 6.84% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold EPR Properties for 45 Days and Tempus AI for 22 Days on average.
| EPR | TEM | |
|---|---|---|
Market Cap | $4.17B | $12.58B |
Volume | 992,716 | 7,444,569 |
Sector | Real Estate | Broad Market / Factor |
52-Week High | $64.32 | $99.28 |
52-Week Low | $48.71 | $41.55 |
Typical Hold Time | 45 Days | 22 Days |
Enterprise Value | $7.68B | $13.21B |
Dividend Yield | 6.84% | — |
Signals from Pluang's Aura AI — not financial advice
EPR Properties (EPR) trades at $54.08, down 2.15% today, with a bearish technical signal and oversold RSI suggesting potential reversal. The REIT maintains strong fundamentals with 91.41% gross margins and consistent dividend payments, though recent earnings showed a Q1 miss. Analyst consensus remains positive with a $65.50 price target, representing 21% upside from current levels.
EPR offers attractive income potential with a 6.5% dividend yield and diversified real estate portfolio, but faces headwinds from rising interest rates and mixed earnings performance. The stock's current valuation at 17.44 P/E appears reasonable, though technical weakness and negative cash flow projections for 2026 warrant caution for near-term investors.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite recent weakness. The company reported Q2 2026 revenue growth of 22% year-over-year and beat EPS estimates for three consecutive quarters, though it remains unprofitable with a net income margin of -17.77%. Recent positive developments include FDA clearance for its ECG-MR AI product and expanded data licensing agreements, fueling investor optimism in the healthtech sector.
The investment outlook is cautiously optimistic, driven by strong analyst support (64% buy ratings) and a consensus price target of $72.60, implying modest upside. Key opportunities include accelerating adoption of AI-powered diagnostics and strategic acquisitions, but risks persist from persistent cash burn, insider selling, and intense competition in the precision medicine space.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
EPR Properties is a REIT specializing in experiential real estate, including movie theaters and leisure destinations like ski resorts and water parks across the US and Canada.
Read more on EPR →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →